Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies

被引：0
|
作者：
P Hamberg
N Steeghs
W J Loos
D van de Biessen
M den Hollander
M Tascilar
J Verweij
H Gelderblom
S Sleijfer
机构：
[1] Erasmus University Medical Center Daniel Den Hoed Cancer Center,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Medical Oncology
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
sunitinib; ifosfamide; pharmacokinetic; VEGF; drug-interaction; phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1706
页数：7
相关论文
共 50 条
  • [21] A phase I clinical and pharmacokinetic study of ipifarnib in combination with docetaxel in patients with advanced solid malignancies
    Awada, Ahmad
    Zhang, Steven
    Gil, Thierry
    de Valeriola, Dominique
    Lalami, Yassine
    De Porre, Peter
    Piccart-Gebhart, Martine J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 991 - 1003
  • [22] Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
    Kerbusch, T
    Groenewegen, G
    Mathôt, RAA
    Herben, VMM
    Huinink, WWT
    Swart, M
    Ambaum, B
    Rosing, H
    Jansen, S
    Voest, EE
    Beijnen, JH
    Schellens, J
    BRITISH JOURNAL OF CANCER, 2004, 90 (12) : 2268 - 2277
  • [23] Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
    T Kerbusch
    G Groenewegen
    R A A Mathôt
    V M M Herben
    W W ten Bokkel Huinink
    M Swart
    B Ambaum
    H Rosing
    S Jansen
    E E Voest
    J H Beijnen
    J H M Schellens
    British Journal of Cancer, 2004, 90 : 2268 - 2277
  • [24] Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
    M D Michaelson
    A X Zhu
    D P Ryan
    D F McDermott
    G I Shapiro
    L Tye
    I Chen
    P Stephenson
    S Patyna
    A Ruiz-Garcia
    A B Schwarzberg
    British Journal of Cancer, 2013, 108 : 1393 - 1401
  • [25] A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies
    Bruce, Justine Yang
    Kolesar, Jill M.
    Hammers, Hans
    Stein, Mark N.
    Carmichael, Lakeesha
    Eickhoff, Jens
    Johnston, Susan A.
    Binger, Kimberly A.
    Heideman, Jennifer L.
    Perlman, Scott B.
    Jeraj, Robert
    Liu, Glenn
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (03) : 485 - 493
  • [26] Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
    D. Ross Camidge
    Normand Blais
    Derek J. Jonker
    Denis Soulières
    Robert C. Doebele
    Ana Ruiz-Garcia
    Aron Thall
    Ke Zhang
    Scott A. Laurie
    Richard C. Chao
    Laura Q. Chow
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 307 - 319
  • [27] Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
    Camidge, D. Ross
    Blais, Normand
    Jonker, Derek J.
    Soulieres, Denis
    Doebele, Robert C.
    Ruiz-Garcia, Ana
    Thall, Aron
    Zhang, Ke
    Laurie, Scott A.
    Chao, Richard C.
    Chow, Laura Q.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 307 - 319
  • [28] A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
    Rini, Brian I.
    Garcia, Jorge A.
    Cooney, Matthew M.
    Elson, Paul
    Tyler, Allison
    Beatty, Kristi
    Bokar, Joseph
    Mekhail, Tarek
    Bukowski, R. M.
    Budd, G. Thomas
    Triozzi, Pierre
    Borden, Ernest
    Ivy, Percy
    Chen, Helen X.
    Dolwati, Afshin
    Dreicer, Robert
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6277 - 6283
  • [29] A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors
    S. Leong
    S. G. Eckhardt
    E. Chan
    W. A. Messersmith
    J. Spratlin
    D. R. Camidge
    S. Diab
    R. Khosravan
    X. Lin
    E. Chow Maneval
    A. C. Lockhart
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 65 - 74
  • [30] A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors
    Leong, S.
    Eckhardt, S. G.
    Chan, E.
    Messersmith, W. A.
    Spratlin, J.
    Camidge, D. R.
    Diab, S.
    Khosravan, R.
    Lin, X.
    Maneval, E. Chow
    Lockhart, A. C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 65 - 74
12345